Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Accelerate Diagnosti (AXDX)

Accelerate Diagnosti (AXDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 455,388
  • Shares Outstanding, K 61,044
  • Annual Sales, $ 11,170 K
  • Annual Income, $ -78,210 K
  • 60-Month Beta 1.96
  • Price/Sales 39.58
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AXDX with:

Options Overview

Details
  • Implied Volatility 83.82%
  • Historical Volatility 59.98%
  • IV Percentile 42%
  • IV Rank 21.89%
  • IV High 202.28% on 01/27/21
  • IV Low 50.62% on 05/25/21
  • Put/Call Vol Ratio 0.17
  • Today's Volume 105
  • Volume Avg (30-Day) 169
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 7,286
  • Open Int (30-Day) 7,115

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.35
  • Number of Estimates 2
  • High Estimate -0.33
  • Low Estimate -0.37
  • Prior Year -0.35
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.44 +7.61%
on 07/16/21
8.05 -13.89%
on 08/03/21
-1.02 (-12.83%)
since 07/02/21
3-Month
6.44 +7.61%
on 07/16/21
9.36 -25.96%
on 06/14/21
-0.26 (-3.62%)
since 05/04/21
52-Week
6.44 +7.61%
on 07/16/21
17.82 -61.11%
on 08/07/20
-8.25 (-54.35%)
since 08/04/20

Most Recent Stories

More News
Accelerate Diagnostics Announces CE Mark and Availability in Europe of Fast Antimicrobial Susceptibility Test for Use with Existing ID Systems

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the new IVD configuration of its Accelerate PhenoTest BC kit has been CE marked and is ready for use in .

AXDX : 6.93 (-8.70%)
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AXDX : 6.93 (-8.70%)
Accelerate Diagnostics Schedules Call to Review 2nd Quarter 2021 Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 5, 2021, at 4:30 p.m. Eastern Time to review 2021 second quarter financial...

AXDX : 6.93 (-8.70%)
Bloodstream Infection Testing Market growth in Life Sciences Tools & Services Industry | Technavio

/PRNewswire/ -- The "bloodstream infection testing market segmented by Technology (Conventional testing and Non-conventional testing) and Geography (, , , and ROW) - Forecast and Analysis 2021-2025" has...

AXDX : 6.93 (-8.70%)
Specific Diagnostics Announces that Romney Humphries has Joined its Scientific Advisory Board

/PRNewswire-PRWeb/ -- Specific Diagnostics announces that Vanderbilt Professor has joined its Scientific Advisory Board. Dr. Humphries is a national leader in antibiotic susceptibility testing, its regulatory...

AXDX : 6.93 (-8.70%)
Accelerate Diagnostics Launches a Fast Antimicrobial Susceptibility Test for Use with Existing ID Systems in the United States

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the launch of a new IVD configuration of its Accelerate PhenoTest BC kit in . With this launch, the Company now provides two...

AXDX : 6.93 (-8.70%)
New Accelerate Pheno® Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that it will have 3 data presentations from its Study at the European Congress of Clinical Microbiology & Infectious Diseases...

AXDX : 6.93 (-8.70%)
New Strong Sell Stocks for June 2nd

BEP, AXDX, FURY, KBAL, and LUNA have been added to the Zacks Rank #5 (Strong Sell) List on June 2, 2021

AXDX : 6.93 (-8.70%)
BEP : 38.33 (-1.21%)
KBAL : 12.05 (-2.67%)
LUNA : 12.45 (+0.08%)
FURY : 0.9800 (-0.10%)
New Strong Sell Stocks for May 20th

AXDX, CRIS, FSTR, GO, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2021

PRLB : 79.80 (+1.93%)
FSTR : 18.01 (-0.77%)
CRIS : 7.19 (+2.86%)
AXDX : 6.93 (-8.70%)
GO : 32.89 (-2.05%)
Accelerate Diagnostics to Participate in William Blair 41st Annual Growth Stock Conference on June 3, 2021

, /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, , and Chief Financial Officer, , will present virtually at the William Blair 41 Annual Growth...

AXDX : 6.93 (-8.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections...

See More

Key Turning Points

3rd Resistance Point 8.01
2nd Resistance Point 7.78
1st Resistance Point 7.36
Last Price 6.93
1st Support Level 6.70
2nd Support Level 6.47
3rd Support Level 6.05

See More

52-Week High 17.82
Fibonacci 61.8% 13.47
Fibonacci 50% 12.13
Fibonacci 38.2% 10.79
Last Price 6.93
52-Week Low 6.44

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar